Abstract
Post-embolisation syndrome (PES) is a prevalent complication that occurs in patients following uterine artery embolisation (UAE) for the treatment of uterine fibroids. The aetiology of PES remains incompletely understood, although postulated to result secondary to tissue infarction resulting in release of inflammatory mediators. We followed PRISMA guidelines and performed a systematic review of studies of PES following UAE from inception to October 2022. Our published protocol was prospectively registered. Our search yielded 54 results. We reviewed 22 full texts, and nine articles were included. Observational studies comprised 6/9 relevant studies, with 5/9 retrospective design. The rate of PES was documented in 5/8 studies (excluding case report) with a reported incidence ranging from 4–34.6%. Five of the nine studies studies postulated that the aetiological basis of PES is inflammatory related. Further research is necessary to advance our understanding of PES to define the biological basis of the syndrome with more certainty and gain a consensus on peri-procedure management to reduce incidence and improve patient outcomes.
Reference24 articles.
1. Epidemiology and management of uterine fibroids;Int. J. Gynecol Obstet.,2020
2. Hormones and pathogenesis of uterine fibroids;Best Pract. Res. Clin. Obs. Gynaecol.,2016
3. Uterine-Artery Embolization versus Surgery for Symptomatic Uterine Fibroids;N. Engl. J. Med.,2007
4. National Institute of Clinical Excellance (2022, October 13). Uterine Artery Embolisation for Fibroids. Interv Proced Guid IPG367. Available online: https://www.nice.org.uk/guidance/ipg367.
5. Complications after benign hysterectomy, according to procedure: A population-based prospective cohort study from the Danish hysterectomy database, 2004–2015;BJOG Int. J. Obs. Gynaecol,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献